Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.7.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Research and development    
Compensation and benefits $ 7,001,151 $ 4,374,763
Consultants and outside costs 762,670 1,317,465
Material manufacturing costs 2,596,809 2,414,708
Facilities and other costs 1,734,104 1,341,452
Research and development 12,094,734 9,448,388
General and administrative    
Compensation and benefits 5,569,426 3,891,916
Professional fees 1,100,480 441,978
Investor relations 327,556 259,351
General and administrative 1,231,852 909,657
General and Administrative 8,229,314 5,502,902
Total operating expenses 20,324,048 14,951,290
Loss from operations (20,324,048) (14,951,290)
Other income (expense)    
Interest income 0 965
Interest expense (1,595) (5,039)
Rental income 37,144 0
Derivative income 11,367 19,822
Total other income 46,916 15,748
Net loss (20,277,132) (14,935,542)
Warrant modification deemed dividend (3,406,932) 0
Cummulative preferred stock dividend 0 (5,974,385)
Net Loss attributable to common stock $ (23,684,064) $ (20,909,927)
Net loss per common share - basic and diluted $ (0.57) $ (0.84)
Weighted average number of common shares outstanding - basic and diluted 41,296,741 24,773,213